{"url": "http://www.philly.com/philly/health/cancer/Promising-therapy-for-rare-eye-cancer-raises-hopes-for-targeting-other-cancers.html", "text": "While the disease is rare, with about 3,100 new diagnoses and 330 deaths in the United States each year, it often goes undiagnosed until it affects vision. Sacks \u2014 known for books including Awakenings and The Mind's Eye, in which he tells the story of his own cancer \u2014 said his symptoms hit suddenly, wiping out a triangular chunk of the vision in his right eye.", "images": ["https://www.inquirer.com/resizer/fKm4SllKk6mkn6M0rH7ozwenANs=/500x500/left/top/media.inquirer.com/storage/inquirer/covers/inqFrontPage.jpg%3Fd=20191111-13", "http://media.philly.com/images/RS_galleryImages_x_20170426_hs1eyecancer30_a.jpg", "https://www.inquirer.com/resizer/F-N8i3PLND7jI2semtOn2AwLUlE=/150x150/left/top/media.inquirer.com/storage/dailynews/covers/front.jpg%3Fd=20191111-13", "https://www.inquirer.com/resizer/QhsSiv5Pp6R9UYYdEXuIxRWg5vk=/150x150/left/top/media.inquirer.com/storage/inquirer/covers/inqFrontPage.jpg%3Fd=20191111-13", "https://www.inquirer.com/resizer/P0EHv7XwRp9Ip-NEdUO9xOVtfow=/500x500/left/top/media.inquirer.com/storage/dailynews/covers/front.jpg%3Fd=20191111-13", "https://www.inquirer.com/resizer/iFKbUZCYRrL0Bqj6k5hNFO4-IU8=/1400x932/smart/arc-anglerfish-arc2-prod-pmn.s3.amazonaws.com/public/U2KCE4RRGNBZ5GDOQHSKTWKF3U.jpg", "http://media.philly.com/images/RS_galleryImages_1200x800_20170426_hs1eyecancer30_c.jpg", "https://www.inquirer.com/resizer/rja7081SPCiBBYqoIcbs5stJK0E=/1200x0/center/middle/www.inquirer.com/resizer/lbtEIH08qzvmf3irpdw1hN6NINc=/1200x0/center/middle/arc-anglerfish-arc2-prod-pmn.s3.amazonaws.com/public/U2KCE4RRGNBZ5GDOQHSKTWKF3U.jpg", "http://media.philly.com/images/RS_galleryImages_x_20170426_hs1eyecancer30_b.jpg.png", "http://media.philly.com/images/RS_galleryImages_x_20170426_hs1eyecancer30_d.jpg"], "top_img": "https://www.inquirer.com/resizer/rja7081SPCiBBYqoIcbs5stJK0E=/1200x0/center/middle/www.inquirer.com/resizer/lbtEIH08qzvmf3irpdw1hN6NINc=/1200x0/center/middle/arc-anglerfish-arc2-prod-pmn.s3.amazonaws.com/public/U2KCE4RRGNBZ5GDOQHSKTWKF3U.jpg", "keywords": [], "authors": ["Marie Mccullough", "Staff Writer", "Drew A. Harris", "For The Inquirer", "James Macpherson", "Associated Press", "Stacey Burling", "Ashley B. Greenblatt", "Richard Cohen", "Tom Avril"], "canonical_link": "https://www.inquirer.com/philly/health/cancer/Promising-therapy-for-rare-eye-cancer-raises-hopes-for-targeting-other-cancers.html", "title": "Novel therapy for rare eye cancer holds promise for targeting other tumors", "meta_data": {"viewport": "width=device-width, minimum-scale=1, initial-scale=1", "copyright": "(c) 2019 The Philadelphia Inquirer, LLC", "distribution": "global", "rating": "general", "application-name": "The Philadelphia Inquirer, LLC", "date": "2017-04-25T07:44:10Z", "description": "Wills Eye hospital is testing an experimental, laser-activated drug that selectively targets ocular melanoma. If successful, it would be the first therapy to preserve vision.", "robots": "index,follow", "googlebot-news": "index", "googlebot": "index", "twitter": {"title": "Novel therapy for rare eye cancer holds promise for targeting other tumors", "image": "https://www.inquirer.com/resizer/rja7081SPCiBBYqoIcbs5stJK0E=/1200x0/center/middle/www.inquirer.com/resizer/lbtEIH08qzvmf3irpdw1hN6NINc=/1200x0/center/middle/arc-anglerfish-arc2-prod-pmn.s3.amazonaws.com/public/U2KCE4RRGNBZ5GDOQHSKTWKF3U.jpg", "card": "summary_large_image", "description": "Wills Eye hospital is testing an experimental, laser-activated drug that selectively targets ocular melanoma. If successful, it would be the first therapy to preserve vision.", "site": "@PhillyInquirer", "creator": "@PhillyInquirer"}, "fb_title": "Novel therapy for rare eye cancer holds promise for targeting other tumors", "og": {"title": "Novel therapy for rare eye cancer holds promise for targeting other tumors", "image": "https://www.inquirer.com/resizer/rja7081SPCiBBYqoIcbs5stJK0E=/1200x0/center/middle/www.inquirer.com/resizer/lbtEIH08qzvmf3irpdw1hN6NINc=/1200x0/center/middle/arc-anglerfish-arc2-prod-pmn.s3.amazonaws.com/public/U2KCE4RRGNBZ5GDOQHSKTWKF3U.jpg", "description": "Wills Eye hospital is testing an experimental, laser-activated drug that selectively targets ocular melanoma. If successful, it would be the first therapy to preserve vision.", "locale": "en_US", "site_name": "https://www.inquirer.com", "type": "article"}, "fb": {"pages": 6130721655}, "article": {"opinion": "false", "section": "Health, Health, Business, Health & Pharma, Our Writers,, Health, Archive, Health"}, "author": "Marie McCullough, STAFF WRITER", "vf": {"unique_id": "XOIMCFB7G5CBNMVJ4XUVGQMVKI"}}, "movies": [], "publish_date": null, "source": "http://www.philly.com", "summary": ""}